Preclinical Component

Preclinical Component

Principal Investigator: Rachel Penrod-Martin, Ph.D.                                              Co-Investigator: Onder Albayram, Ph.D.                                                                                 

As medicalization and legalization of cannabis products for recreational use has increased use across many sensitive age groups, understanding how sex and age interact to perpetuate cannabis use disorder is more crucial now than ever. The goal of the Preclinical Component is to examine the behavioral and biological underpinnings of cannabis use that differ between sex and age groups and enhance and inform the clinical projects through investigation of biological endpoints associated with THC use in emerging adults, aged adults, and gestational females using translationally relevant behavioral and biological assessments in rats.